Evidence map›Paper›PMID 38188232›Full record

ArticleNeuroprotection (Chichester, England)2023

Activation of neurogenesis in the hippocampus is a novel therapeutic target for Alzheimer's disease.

Akihiko Taguchi, Yuka Okinaka, Akiko Takeda, Takayuki Okamoto, Johannes Boltze, Carsten Claussen, Sheraz Gul

Abstract read
In one paragraph

Article in Neuroprotection (Chichester, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Mitigating the impact of mechanisms causing neuronal degeneration.Neuroprotection (Chichester, England) · 2024
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Akihiko TaguchiDepartment of Regenerative Medicine Research, Foundation for Biomedical Research and Innovation at Kobe, Hyogo, Japan.ORCID 0000-0003-2765-4621
Yuka OkinakaDepartment of Regenerative Medicine Research, Foundation for Biomedical Research and Innovation at Kobe, Hyogo, Japan.
Akiko TakedaDepartment of Regenerative Medicine Research, Foundation for Biomedical Research and Innovation at Kobe, Hyogo, Japan.
Takayuki OkamotoDepartment of Pharmacology, Faculty of Medicine, Shimane University, Izumo, Shimane, Japan.
Johannes BoltzeDepartment of Regenerative Medicine Research, Foundation for Biomedical Research and Innovation at Kobe, Hyogo, Japan.ORCID 0000-0003-3956-4164
Carsten ClaussenFraunhofer Institute for Translational Medicine and Pharmacology ITMP, Hamburg, Germany.
Sheraz GulFraunhofer Institute for Translational Medicine and Pharmacology ITMP, Hamburg, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Alzheimer’s diseasecell-cell interactioncell therapygap junctionsneurodegenerative diseaseneurogenesis

Identifiers

PMID38188232
PMCPMC7615480

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.